Magnolia Medical

The proven solution to significantly reduce blood culture contamination by an average of 93%.

Your path to improved patient care.
Your path to savings.

SteriPath
SteriPath Clinical Trial Results
See How SteriPath Works
What Makes SteriPath Unique

CID Peer-Reviewed Published Study on Breakthrough Blood Culture Collection Technology

Clinical Infectious Diseases journal has published the results of a study from the University of Nebraska Medical Center led by Dr. Mark E. Rupp, Professor and Chief of UNMC Division of Infectious Diseases and Medical Director of the Department of Infection Control and Epidemiology at Nebraska Medicine, UNMC’s hospital partner. The study validates the performance of the SteriPath blood collection system to reduce blood culture contamination to 0.2%. 

Learn More >
SteriPath

See Our Patents

Magnolia Medical has a broad and growing portfolio of patents covering methods & devices for collecting bodily-fluid specimens with reduced contamination.

Learn More >
SteriPath